These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
448 related items for PubMed ID: 20720199
21. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle. Johansen HK, Cryz SJ, Hougen HP, Moser C, Høiby N. Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750 [Abstract] [Full Text] [Related]
22. Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibition of COX-2. Sadikot RT, Zeng H, Azim AC, Joo M, Dey SK, Breyer RM, Peebles RS, Blackwell TS, Christman JW. Eur J Immunol; 2007 Apr; 37(4):1001-9. PubMed ID: 17330822 [Abstract] [Full Text] [Related]
23. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice. Wareing MD, Lyon AB, Lu B, Gerard C, Sarawar SR. J Leukoc Biol; 2004 Oct; 76(4):886-95. PubMed ID: 15240757 [Abstract] [Full Text] [Related]
24. Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease. Rieber N, Brand A, Hector A, Graepler-Mainka U, Ost M, Schäfer I, Wecker I, Neri D, Wirth A, Mays L, Zundel S, Fuchs J, Handgretinger R, Stern M, Hogardt M, Döring G, Riethmüller J, Kormann M, Hartl D. J Immunol; 2013 Feb 01; 190(3):1276-84. PubMed ID: 23277486 [Abstract] [Full Text] [Related]
25. A disturbed interaction with accessory cells upon opportunistic infection with Pseudomonas aeruginosa contributes to an impaired IFN-γ production of NK cells in the lung during sepsis-induced immunosuppression. Pastille E, Pohlmann S, Wirsdörfer F, Reib A, Flohé SB. Innate Immun; 2015 Feb 01; 21(2):115-26. PubMed ID: 24406749 [Abstract] [Full Text] [Related]
26. Mice Lacking γδ T Cells Exhibit Impaired Clearance of Pseudomonas aeruginosa Lung Infection and Excessive Production of Inflammatory Cytokines. Omar T, Ziltener P, Chamberlain E, Cheng Z, Johnston B. Infect Immun; 2020 May 20; 88(6):. PubMed ID: 32229615 [Abstract] [Full Text] [Related]
27. Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome. Faure E, Mear JB, Faure K, Normand S, Couturier-Maillard A, Grandjean T, Balloy V, Ryffel B, Dessein R, Chignard M, Uyttenhove C, Guery B, Gosset P, Chamaillard M, Kipnis E. Am J Respir Crit Care Med; 2014 Apr 01; 189(7):799-811. PubMed ID: 24555512 [Abstract] [Full Text] [Related]
28. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. LeVine AM, Kurak KE, Bruno MD, Stark JM, Whitsett JA, Korfhagen TR. Am J Respir Cell Mol Biol; 1998 Oct 01; 19(4):700-8. PubMed ID: 9761768 [Abstract] [Full Text] [Related]
29. Early Growth Response 1 Deficiency Protects the Host against Pseudomonas aeruginosa Lung Infection. Pang Z, Raudonis R, McCormick C, Cheng Z. Infect Immun; 2019 Dec 17; 88(1):. PubMed ID: 31611276 [Abstract] [Full Text] [Related]
30. Macrophage FABP4 is required for neutrophil recruitment and bacterial clearance in Pseudomonas aeruginosa pneumonia. Liang X, Gupta K, Quintero JR, Cernadas M, Kobzik L, Christou H, Pier GB, Owen CA, Çataltepe S. FASEB J; 2019 Mar 17; 33(3):3562-3574. PubMed ID: 30462529 [Abstract] [Full Text] [Related]
31. Limited role for interleukin-18 in the host protection response to pulmonary infection with Pseudomonas aeruginosa in mice. Nakasone C, Kawakami K, Hoshino T, Kawase Y, Yokota K, Yoshino K, Takeda K, Akira S, Saito A. Infect Immun; 2004 Oct 17; 72(10):6176-80. PubMed ID: 15385528 [Abstract] [Full Text] [Related]
32. Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus. Skerrett SJ, Liggitt HD, Hajjar AM, Wilson CB. J Immunol; 2004 Mar 15; 172(6):3377-81. PubMed ID: 15004134 [Abstract] [Full Text] [Related]
33. IRF-3, IRF-7, and IPS-1 promote host defense against acute human metapneumovirus infection in neonatal mice. Spann KM, Loh Z, Lynch JP, Ullah A, Zhang V, Baturcam E, Werder RB, Khajornjiraphan N, Rudd P, Loo YM, Suhrbier A, Gale M, Upham JW, Phipps S. Am J Pathol; 2014 Jun 15; 184(6):1795-806. PubMed ID: 24726644 [Abstract] [Full Text] [Related]
34. Regulator of calcineurin 1 suppresses inflammation during respiratory tract infections. Junkins RD, MacNeil AJ, Wu Z, McCormick C, Lin TJ. J Immunol; 2013 May 15; 190(10):5178-86. PubMed ID: 23589609 [Abstract] [Full Text] [Related]
35. The nuclear factor kappa-B pathway in airway epithelium regulates neutrophil recruitment and host defence following Pseudomonas aeruginosa infection. Chen SM, Cheng DS, Williams BJ, Sherrill TP, Han W, Chont M, Saint-Jean L, Christman JW, Sadikot RT, Yull FE, Blackwell TS. Clin Exp Immunol; 2008 Sep 15; 153(3):420-8. PubMed ID: 18647324 [Abstract] [Full Text] [Related]
36. Pathophysiological changes induced by Pseudomonas aeruginosa infection are involved in MMP-12 and MMP-13 upregulation in human carcinoma epithelial cells and a pneumonia mouse model. Park JW, Shin IS, Ha UH, Oh SR, Kim JH, Ahn KS. Infect Immun; 2015 Dec 15; 83(12):4791-9. PubMed ID: 26438797 [Abstract] [Full Text] [Related]
37. PTP1B negatively regulates STAT1-independent Pseudomonas aeruginosa killing by macrophages. Yue L, Yan M, Chen S, Cao H, Li H, Xie Z. Biochem Biophys Res Commun; 2020 Dec 10; 533(3):296-303. PubMed ID: 32958258 [Abstract] [Full Text] [Related]
38. Early production of IL-17 protects against acute pulmonary Pseudomonas aeruginosa infection in mice. Liu J, Feng Y, Yang K, Li Q, Ye L, Han L, Wan H. FEMS Immunol Med Microbiol; 2011 Mar 10; 61(2):179-88. PubMed ID: 21204996 [Abstract] [Full Text] [Related]
39. IL-27 controls sepsis-induced impairment of lung antibacterial host defence. Cao J, Xu F, Lin S, Song Z, Zhang L, Luo P, Xu H, Li D, Zheng K, Ren G, Yin Y. Thorax; 2014 Oct 10; 69(10):926-37. PubMed ID: 25074706 [Abstract] [Full Text] [Related]